Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-20-002997
Filing Date
2020-11-16
Accepted
2020-11-16 14:21:39
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13G sc13g11265005_11162020.htm SC 13G 221344
2 JOINT FILING AGREEMENT ex991to13g11265005_11162020.htm EX-99.1 14876
  Complete submission text file 0000921895-20-002997.txt   237918
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Subject) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-79996 | Film No.: 201315602
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7415 FOXWORTH COURT JACKSON MI 49201
Business Address 7415 FOXWORTH COURT JACKSON MI 49201 517-536-5000
Richmond Brothers, Inc. (Filed by) CIK: 0001540462 (see all company filings)

EIN.: 205152300 | State of Incorp.: MI | Fiscal Year End: 1231
Type: SC 13G